Literature DB >> 10771232

Optical and atomic force microscopy of an explanted AcrySof intraocular lens with glistenings.

M Dogru1, K Tetsumoto, Y Tagami, K Kato, K Nakamae.   

Abstract

PURPOSE: To assess the surface morphology and cause of glistenings in an explanted AcrySof intraocular lens (IOL).
SETTING: Shakai Hoken Kobe Central Hospital, Kobe, Japan.
METHODS: A 63-year-old Japanese man had implantation of an AcrySof IOL in the capsular bag. One month postoperatively, he had a neodymium:YAG laser capsulotomy for posterior capsule opacification, which changed the IOL's position in the capsular bag. A few months later, the patient developed disabling night glare from intralenticular glistenings and progressive hyperopic refractive error. The IOL was explanted and then analyzed by optical microscopy and atomic force microscopy (AFM). Laboratory analysis of control AcrySof IOLs kept in a balanced salt solution at steady room and body temperature for 2 months was also performed to evaluate the cause of the glistenings observed clinically.
RESULTS: Optical microscopy showed that the explanted AcrySof IOL had several microvacuoles; no abnormalities were observed in the control AcrySof IOLs before or after folding at the room and body temperatures. The AFM analysis showed a significant change in the surface morphology of the explanted IOL, including vacuolar formations in the posterior surface as well as numerous anterior surface irregularities. No microvacuoles or surface morphology alterations were observed in the control AcrySof IOLs by AFM analysis.
CONCLUSIONS: The glistenings in the explanted AcrySof IOL were likely caused by temperature changes and not mechanical stress from folding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771232     DOI: 10.1016/s0886-3350(99)00342-9

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Influence of glistenings on the optical quality of acrylic foldable intraocular lens.

Authors:  T Oshika; Y Shiokawa; S Amano; K Mitomo
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  Opacification of SC60B-OUV lens implant following routine phacoemulsification surgery: case report and EM study.

Authors:  A Moosavi; P Fox; M Harrison; G J Phillips; A W Lloyd
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  Measurements of elastic modulus for human anterior lens capsule with atomic force microscopy: the effect of loading force.

Authors:  Konstantinos T Tsaousis; Panagiotis G Karagiannidis; Nikolaos Kopsachilis; Chrysanthos Symeonidis; Ioannis T Tsinopoulos; Varvara Karagkiozaki; Lampros P Lamprogiannis; Stergios Logothetidis
Journal:  Int Ophthalmol       Date:  2013-09-15       Impact factor: 2.031

4.  Intraocular lens opacification mimicking the appearance of a congenital lamellar cataract.

Authors:  C Patel; S Hamada; Y Athanasiadis; R Bates; G M Saleh
Journal:  Eye (Lond)       Date:  2012-08-31       Impact factor: 3.775

5.  Effects of intraocular lens glistenings on visual function: a prospective study and presentation of a new glistenings grading methodology.

Authors:  Nick Stanojcic; David P S O'Brart; Nick Maycock; Chistopher C Hull
Journal:  BMJ Open Ophthalmol       Date:  2019-04-01

6.  In-vitro glistening formation in six different foldable hydrophobic intraocular lenses.

Authors:  Tamer Tandogan; Gerd U Auffarth; Hyeck-Soo Son; Patrick Merz; Chul Young Choi; Ramin Khoramnia
Journal:  BMC Ophthalmol       Date:  2021-03-08       Impact factor: 2.209

Review 7.  Clinical properties of a novel, glistening-free, single-piece, hydrophobic acrylic IOL.

Authors:  Mark Packer; Mohan Rajan; Edoardo Ligabue; Peter Heiner
Journal:  Clin Ophthalmol       Date:  2014-02-21

8.  Comparative analysis of in vitro accelerated glistening formation in foldable hydrophobic intraocular lenses.

Authors:  Tamer Tandogan; Gerd U Auffarth; Chul Young Choi; Hyeck-Soo Son; Ramin Khoramnia
Journal:  Int Ophthalmol       Date:  2021-05-19       Impact factor: 2.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.